"When Privacy Trumps Prudent Public Health and the Provision of Lifesaving Care, We've Gone Too Far" AIDS Healthcare Foundation, the largest global AIDS organization, today criticized the ACLU of Northern California, Lambda Legal and the HIV & AIDS Legal Services Alliance for their willingness to sacrifice the health and wellbeing of low-income Cal
Sept. 10Illegally marketing an anti-convulsant drug as treatment for a variety of psychiatric conditions will result in Ortho-McNeil-Janssen Pharmaceuticals paying $526,903 to Wisconsin's Medicaid program as part of a settlement, according to the state Department of Justice. The drug company marketed Topamax "off-label," meaning for conditions no
3M announced that Premier, Inc., a company specializing in healthcare performance improvement, has awarded a sole source contract to 3M for their Sterilization Assurance products, which include biological and chemical indicators, Bowie Dick tests, and indicator tapes.
Soligenix, Inc., a late-stage biopharmaceutical company, announced that it has been awarded a three year $1.2 million clinical research grant by the Office of Orphan Products Development of the U.S. Food and Drug Administration pursuant to its Orphan Products Development Program.
Sept. 09Federal regulators decided not to disqualify a prominent North Side HIV doctor whose clinic submitted fictitious data in a drug trial. Instead, the Food and Drug Administration agreed to allow Dr. Daniel Berger to continue working on drug trials as long as an outside medical monitor periodically reviews his work for three years. "I feel a
Amedisys, Inc., one of America's leading home health and hospice companies, today announced that executives from Amedisys will present at two upcoming conferences. The first presentation will be at the Robert W. Baird & Company 2010 Health Care Conference in New York, NY on Tuesday, September 14, 2010.
Last Frontier in Patient Monitoring Now Conquered: Noninvasive and Continuous Temperature Monitoring Has Arrived. Brain Tunnelgenix Technologies Corp. announced today that the U.S. Food and Drug Administration has granted the company clearance to market its Abreu BTT 700 System for continuous temperature monitoring.
ALISO VIEJO, Calif., Sept. 9 Clarient, Inc., a premier anatomic pathology and molecular testing services resource for pathologists, oncologists and the biopharmaceutical industry, today announced that the Company's presentation time at the Baird 2010 Health Care Conference has changed to 9:00 am EDT on Tuesday, September 14, 2010.
WOONSOCKET, R.I., Sept. 9 CVS Caremark today said that ongoing research into how behavioral economics impacts health care choices found that when consumers are presented with a clear and active choice in a voice-recorded message to select automatic prescription refills, rather than a passive default notification, they are twice as likely to choose
PRINCETON, N.J., Sept. 9 New Jersey is a model of diversity. But a state rich in diversity also faces healthcare challenges. With that landscape as a backdrop, the State of New Jersey has declared September Minority and Multicultural Health Month. "Cookie-cutter healthcare won't cut it in a state as diverse as New Jersey," said NJHA President and C
The U.S. Department of Health and Human Services' Food and Drug Administration issued the following news release: The U.S. Food and Drug Administration today issued warning letters to five electronic cigarette distributors for various violations of the Federal Food, Drug, and Cosmetic Act including unsubstantiated claims and poor manufacturing prac
To: HEALTH, MEDICAL, AND NATIONAL EDITORS. Contact: Sandy Walsh of FDA, +1-301-796-4669, sandy.walsh@fda.hhs.gov. The U.S. Food. and Drug Administration has approved the pediatric use of Protopam. Chloride, a drug used to treat poisoning by. organophosphate pesticides and chemicals. The. drug is approved to be administered either by intravenous or.
The U.S. Department of Health and Human Services' Food and Drug Administration issued the following news release: The U.S. Food and Drug Administration has approved the pediatric use of Protopam Chloride, a drug used to treat poisoning by organophosphate pesticides and chemicals.
To: HEALTH, AND NATIONAL EDITORS. Contact: Siobhan DeLancey of the U.S. Food and Drug Administration, +1-301-796-4668, siobhan.delancey@fda.hhs.gov. Agency cites unsubstantiated claims, poor manufacturing practices. The U.S. Food. and Drug Administration today issued warning letters to five. distributors for various violations of the Federal Food,
FDA NEWS RELEASE. FDA approves pediatric use of chemical poisoning treatment. The U.S. Food and Drug Administration has approved the pediatric use of Protopam Chloride, a drug used to treat poisoning by organophosphate pesticides and chemicals.
ATLANTA, Sept. 9 Gentiva Health Services, Inc., the nation's largest provider of home health and hospice services, announced today that it will present at the Baird 2010 Health Care Conference in New York at 8:30 a.m. ET on Wednesday, September 15, 2010 and the Stifel Nicolaus 2010 Health Care Conference in Boston at 2:05 p.m. ET on Thursday, Septe
New App for iPhone and iPod touch Allows Members to Connect to Their Accounts, Conduct Business and Quickly Access Vital Information. Members of Health Net, Inc. now have mobile access to their accounts and other key details - like maps and directions to their nearest urgent care center - providing on-the-go capabilities to conduct business and qui
Hospira, Inc., a leading provider of clinical information and medication delivery technologies, and Smiths Medical, a leading global medical device manufacturer, today announced a commercial collaboration and co-development agreement for infusion pump systems.
MONTEREY, Calif., Sept. 9 Language Line Services, the leading provider of language-based solutions and the number one provider of over-the-phone interpreting services for the healthcare industry, announced a program of support, instructional materials and consultations to help ensure compliance for hospitals as they gear up for the new Joint Commis
To: HEALTH, AND STATE EDITORS. Contact: Kerry McKean Kelly, New Jersey Hospital Association, +1-609-275-4069, kmckean@njha.com. New Jersey is a. model of diversity. nations, and the U.S. Census Bureau ranks the Garden State third in. the nation in the percentage of foreign-born residents. But a state rich in diversity also faces healthcare challeng
Healthcare supplier Perrigo Company declared on Wednesday the receipt of approval from the US Food and Drug Administration to manufacture and market Imiquimod Cream, 5%. The company said it will vertically integrate Imiquimod Cream, 5% with its own API.
A new study, 'Sunlight robbery: a critique of public health policy on vitamin D in the UK,' is now available. "Few food products are fortified with vitamin D in the UK and the government does not recommend any vitamin D supplement for most adults in the UK.
SYSPRO, the leading provider of visionary, pragmatic ERP software, announced that the company is highly confident that the SYSPRO ERP solution will enable pharmaceutical manufacturers to meet the new U.S. Food and Drug Administration regulations being proposed by Congress. Traceability functionality is the key component required to assist in the me
Tenet Healthcare Corporation today announced that Trevor Fetter, Tenet's president and chief executive officer, and Biggs C. Porter, chief financial officer, will speak at the Morgan Stanley Global Healthcare Conference in New York on September 14, 2010 at 8:35 AM. Tenet's remarks will be available live by webcast and may be accessed through the in
Alexion Pharmaceuticals, Inc. announced that the US Food and Drug Administration has approved Alexion's Rhode Island manufacturing facility in Smithfield, Rhode Island as a second source of commercial supply for Soliris. Earlier this year, Alexion reported that the European Medicines Agency had approved ARIMF as a second source of supply for Soli
